Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
12000 participants
OBSERVATIONAL
2020-07-14
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To evaluate risk factors for cancers of the biliary tract by registering new patients and their counterparts in a multi-center program
* Development of programs by creating a multi-center biliary tract cancer registration system
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Newly diagnosed as bile duct cancer
No interventions assigned to this group
Control group
No history of cancer in previous 5 years
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosis of biliary tract cancers - Pathological or Radiological or other clinical diagnosis of biliary tract cancers
* Informed consent
* Control :
* with no previous cancer diagnosis
* Informed consent
Exclusion Criteria
* Prior diagnosis of other cancer in 5 years or ongoing cancer treatment
* Patients' refusal
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Hospital
OTHER
Pusan National University Hospital
OTHER
Pusan National University Yangsan Hospital
OTHER
Kyungpook National University Chilgok Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyungpook National University Chilgok Hospital
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNUCH 2020-04-045
Identifier Type: -
Identifier Source: org_study_id